Characterization of Spontaneous and TGF-β-Induced Cell Motility of Primary Human Normal and Neoplastic Mammary Cells In Vitro Using Novel Real-Time Technology
暂无分享,去创建一个
[1] Olivier De Wever,et al. Comparative Analysis of Dynamic Cell Viability, Migration and Invasion Assessments by Novel Real-Time Technology and Classic Endpoint Assays , 2012, PloS one.
[2] R. Hass,et al. Mesenchymal stem cells as all-round supporters in a normal and neoplastic microenvironment , 2012, Cell Communication and Signaling.
[3] H. Lehnert,et al. The Src family kinase inhibitors PP2 and PP1 effectively block TGF-beta1-induced cell migration and invasion in both established and primary carcinoma cells , 2012, Cancer Chemotherapy and Pharmacology.
[4] Stephanie Alexander,et al. Cancer Invasion and the Microenvironment: Plasticity and Reciprocity , 2011, Cell.
[5] Hendrik Lehnert,et al. Interaction of tumor cells with the microenvironment , 2011, Cell Communication and Signaling.
[6] P. Dijke,et al. The TGF-β/Smad pathway induces breast cancer cell invasion through the up-regulation of matrix metalloproteinase 2 and 9 in a spheroid invasion model system , 2011, Breast Cancer Research and Treatment.
[7] H. Lehnert,et al. Differential roles of Smad2 and Smad3 in the regulation of TGF-β1-mediated growth inhibition and cell migration in pancreatic ductal adenocarcinoma cells: control by Rac1 , 2011, Molecular Cancer.
[8] S. Böhm,et al. Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC , 2011, Cell Communication and Signaling.
[9] R. Hass,et al. Extracellular signals in young and aging breast epithelial cells and possible connections to age-associated breast cancer development , 2011, Mechanisms of Ageing and Development.
[10] P. ten Dijke,et al. TGF-β Signaling in Breast Cancer Cell Invasion and Bone Metastasis , 2011, Journal of Mammary Gland Biology and Neoplasia.
[11] M. Bollet,et al. Management of Phyllodes Breast Tumors , 2011, The breast journal.
[12] S. Sebens,et al. Differential roles of Src in transforming growth factor-ß regulation of growth arrest, epithelial-to-mesenchymal transition and cell migration in pancreatic ductal adenocarcinoma cells. , 2011, International journal of oncology.
[13] Ben Fabry,et al. The role of the tissue microenvironment in the regulation of cancer cell motility and invasion , 2010, Cell Communication and Signaling.
[14] F. Bianchini,et al. Environmental control of invasiveness and metastatic dissemination of tumor cells: the role of tumor cell-host cell interactions , 2010, Cell Communication and Signaling.
[15] A. Lavrentieva,et al. Effects of hypoxic culture conditions on umbilical cord-derived human mesenchymal stem cells , 2010, Cell Communication and Signaling.
[16] Jenny G. Parvani,et al. The Pathophysiology of Epithelial-Mesenchymal Transition Induced by Transforming Growth Factor-β in Normal and Malignant Mammary Epithelial Cells , 2010, Journal of Mammary Gland Biology and Neoplasia.
[17] D. Radisky,et al. Matrix Metalloproteinase-Induced Epithelial-Mesenchymal Transition in Breast Cancer , 2010, Journal of Mammary Gland Biology and Neoplasia.
[18] R. Hass,et al. Cellular senescence of human mammary epithelial cells (HMEC) is associated with an altered MMP-7/HB-EGF signaling and increased formation of elastin-like structures , 2009, Mechanisms of Ageing and Development.
[19] R. Hass,et al. Characterization of human breast cancer epithelial cells (HBCEC) derived from long term cultured biopsies , 2009, Journal of experimental & clinical cancer research : CR.
[20] Cornelia Kasper,et al. Identification of subpopulations in mesenchymal stem cell-like cultures from human umbilical cord , 2009, Cell Communication and Signaling.
[21] P. Porter. Global trends in breast cancer incidence and mortality. , 2009, Salud publica de Mexico.
[22] T. Motyl,et al. Matrix metalloproteinase-2 involvement in breast cancer progression: a mini-review. , 2009, Medical science monitor : international medical journal of experimental and clinical research.
[23] M. Sogayar,et al. Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential , 2009, BMC Cancer.
[24] C. Klein,et al. The Metastasis Cascade , 2008, Science.
[25] E. McSherry,et al. Molecular basis of invasion in breast cancer. , 2007, Cellular and molecular life sciences : CMLS.
[26] E. McSherry,et al. Common Molecular Mechanisms of Mammary Gland Development and Breast Cancer , 2007, Cellular and Molecular Life Sciences.
[27] M. Tiemann,et al. [Coagulation and formation of malignant effusions]. , 2007, Hamostaseologie.
[28] B. Sipos,et al. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function , 2007, Oncogene.
[29] Wei Wei,et al. Metastatic patterns in adenocarcinoma , 2006, Cancer.
[30] Francis Lin,et al. Differential effects of EGF gradient profiles on MDA-MB-231 breast cancer cell chemotaxis. , 2004, Experimental cell research.
[31] Edgar D Staren,et al. Matrix metalloproteinase expression in breast cancer. , 2003, The Journal of surgical research.
[32] A. Reith,et al. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. , 2002, Molecular pharmacology.
[33] N. Harbeck,et al. Clinical relevance of invasion factors urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 for individualized therapy decisions in primary breast cancer is greatest when used in combination. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] N. Brünner,et al. External quality assessment of trans-European multicentre antigen determinations (enzyme-linked immunosorbent assay) of urokinase-type plasminogen activator (uPA) and its type 1 inhibitor (PAI-1) in human breast cancer tissue extracts. , 1998, British Journal of Cancer.
[35] H. Ungefroren,et al. Transcriptional Regulation of the Human Biglycan Gene* , 1996, The Journal of Biological Chemistry.
[36] Hui-Li Qu,et al. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition. , 2013, Oncology reports.
[37] P. Friedl,et al. Cancer invasion and resistance: interconnected processes of disease progression and therapy failure. , 2012, Trends in molecular medicine.
[38] N. Harbeck,et al. Procedures for the quantitative protein determination of urokinase and its inhibitor, PAI-1, in human breast cancer tissue extracts by ELISA. , 2006, Methods in molecular medicine.
[39] Joachim Wegener,et al. Real-time impedance assay to follow the invasive activities of metastatic cells in culture. , 2002, BioTechniques.